The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-κB ligand.
Open accessAbstract
Receptor activator of NF-kappaB ligand (RANKL) is a transmembrane glycoprotein that has an essential role in the development of osteoclasts. The extracellular portion of RANKL is cleaved proteolytically to produce soluble RANKL, but definite RANKL sheddase(s) and the physiologic function of RANKL shedding have not yet been determined. In the present study, we found that matrix metalloproteinase (MMP) 14 and a disintegrin and metalloproteinase (ADAM) 10 have strong RANKL shedding activity. In Western blot analysis, soluble RANKL was detected as two different molecular weight products, and RNA interference of MMP14 and ADAM10 resulted in a reduction of both the lower and higher molecular weight products. Suppression of MMP14 in primary osteoblasts increased membrane-bound RANKL and promoted osteoclastogenesis in cocultures with macrophages. Soluble RANKL produced by osteoblasts from MMP14-deficient mice was markedly reduced, and their osteoclastogenic activity was promoted, consistent with the findings of increased osteoclastogenesis in vivo. RANKL shedding is an important process that down-regulates local osteoclastogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are at least three forms of RANKL, two of which possess a transmembrane domain that positions the biologically active carboxy-terminus to the extracellular domain (i.e., a type II transmembrane protein) (Fig. 2).One of these forms, RANKL2, is a shorter alternative splicing variant of RANKL1 (44).Both of these variants can remain on cell surfaces or can be proteolytically cleaved into soluble”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149
Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701
A matrix metalloproteinase expressed on the surface of invasive tumour cells
Sato, H., Takino, T., Okada, Y., Cao, J. P., Shinagawa, A., Yamamoto, E., & Seiki, M. (1994) · Nature · doi:10.1038/370061a0 · Cited by 2,534
Self-citationOsteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Prenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,507
Flagged first, then by citations
1 of the 41 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–237 of 237
Yu, C., Wang, L., Ni, Y., & Wang, J. (2019) · RSC Advances · doi:10.1039/c9ra07328k · Cited by 1
Osteoimmunology: the effect of inflammation on bone
Nakashima, T., & Takayanagi, H. (2011) · Inflammation and Regeneration · doi:10.2492/inflammregen.31.404 · Cited by 1
Changes in RANKL during the first two years after cART initiation in HIV-infected cART naïve adults
Mathiesen, I. H. M., Salem, M., Gerstoft, J., Gaardbo, J. C., Obel, N., Pedersen, C., Ullum, H., Nielsen, S. D., & Hansen, A. E. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2368-y · Cited by 2
Unusual suspects: dancing with stromal cells
Belz, G. T., & Almeida, F. F. (2017) · Nature Immunology · doi:10.1038/ni.3741 · Cited by 1
Cytokines and the pathogenesis of osteoporosis
Lorenzo, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00033-2 · Cited by 1
On the Role of Osteoprotegerin/RANK/RANKL System in the Interaction between Prostate Cancer and Bone
Penno, H. (2011) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Tawara, K. (2011) · ScholarWorks (Boise State University)
Variable expressions of ADAM family genes in tissues and cancer cells
Kleino, I. (2007) · Tampere University Institutional Repository (Tampere University)
Droghetti, P. R., Cruzat, F., Ferrer, P. S., & Droguett, A. O. (2010) · Revista clínica de periodoncia implantología y rehabilitación oral · doi:10.1016/s0718-5391(10)70051-3
Genetic studies of SH3PXD2B and its contributions to ocular diseases
Mao, M., Anderson, M. G., Henry, M. D., Johnson, W. A., Stamnes, M. A., Russo, A. F., & Slusarski, D. C. (2010) · doi:10.17077/etd.7b7w80l8
The interactions and shared mechanisms of T cells and osteoclasts
Gober, H.-J., & Takayanagi, H. (2009) · Inflammation and Regeneration · doi:10.2492/inflammregen.29.239
Zabroda, S. I., Maslyukova, E. A., Li, K., Раскин, Г. А., Pozharissky, K. M., & Корытов, О. В. (2015) · Tumors of female reproductive system · doi:10.17650/1994-4098-2015-11-2-19-24
Membrane-type 3-Matrix Metalloproteinase (MMP16)
Fu, H.-L., & Fridman, R. A. (2012) · Handbook of Proteolytic Enzymes · doi:10.1016/b978-0-12-382219-2.00166-6
Proteases and Therapeutic Approaches of Bone Tumors
Ruiz, V. C., Fortun, Y., Heymann, D., & Padrines, M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374895-9.00009-8
Drug delivery to osteoclast receptor targets
Kalvapalle, R. (2009) · doi:10.7939/r3ts7w
Osteoclasts in Cardiovascular Calcification
Atkins, S. K., Iqbal, F., Barrientos, J., Giachelli, C. M., & Aïkawa, E. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-46725-8_18
New insight into function and dysfunction of gut microfold cells
Li, Q.-X., Guo, Y., Hua, R., Shang, H.-W., Li, L., & Xu, J. (2021) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v29.i4.197
Bone Development and Remodeling
Maes, C., & Kronenberg, H. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00059-9
Osteoimunologia: uma breve introdução
Souza, J. M. S., & Zerbini, C. A. F. (2012) · Revista Paulista de Reumatologia · doi:10.46833/reumatologiasp.2011.10.s1.30-34
THE THREE KEY PLAYERS IN OSTEOIMMUNOLOGY: RANK, RANKL AND OSTEOPROTEGERIN
Priyanka, T. G., Athul, A., Arulmari, S., Dawson, S. M., Balachandran, A., & Muthukali, S. (2023) · Indian Journal Of Applied Research · doi:10.36106/ijar/1801925
Transcriptional Profiling of Muscle in Females With Distal Radius Fracture and Functional Sarcopenia
Kang, J., Baek, J., Lee, J. K., & Hong, S. W. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae002
Characterization of a spontaneous osteopetrosis model using RANKL-dysfunctional mice
Kim, B. C., Lee, G. C., Jang, Y., Kim, D. O., Ju, J., Lee, C.-M., & Lim, W. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102412
Membrane-type 3-matrix metalloproteinase (MMP16)
Fu, H.-L., & Fridman, R. A. (2025) · Handbook of Proteolytic Enzymes · doi:10.1016/b978-0-443-28849-4.00109-0
Dharmapatni, A. A. S. S. K., Crotti, T. N., Ormsby, R. T., Kogawa, M., Solomon, L. B., Findlay, D. M., Haynes, D. R., & Atkins, G. J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.11.30.691475
Babendreyer, A., Kieselhorst, J., Rinkens, C., Lyashenko, A. M., Düsterhöft, S., Jahr, H., Craveiro, R. B., Wolf, M., & Ludwig, A. (2024) · Figshare · doi:10.6084/m9.figshare.26019551
(2025) · Journal of Dental Health and Oral Research · doi:10.46889/jdhor.2025.6314
Fu, Y., Zhao, Q., Wang, Y., Yang, W., Liu, X., Yang, W., Tan, X., & Meng, Y. (2026) · Placenta · doi:10.1016/j.placenta.2026.01.001
Okamoto, K., & Takayanagi, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00001-3
Micro-environnement et cancer : rôle des adamalysines dans la progression tumorale
Dekky, B. (2018) · theses.fr (ABES) · doi:10.70675/30190222z7377z44fdzbbc4zd0a03a82efd6
Esmaili, H., Asgari, N., Mosayeb, N., & Jafarnejad, S. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.72229
Metadata
- Authors
- Hikita, A., Yana, I., Wakeyama, H., Nakamura, M., Kadono, Y., Oshima, Y., Nakamura, K., Seiki, M., & Tanaka, S.
- Affiliations
- The University of Tokyo (JP)
- Institute of Medical Science, The University of Tokyo (JP)
- Corresponding author
- Tanaka, Sakae
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-12
- Volume
- 281
- Issue
- 48
- Pages
- 36846-36855
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1999201913
- Cited by
- 236
- References
- 41
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 8 · 2023: 15 · 2022: 7 · 2021: 13 · 2020: 15 · 2019: 8 · 2018: 13 · 2017: 17 · 2016: 7 · 2015: 10 · 2014: 9 · 2013: 8 · 2012: 12
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- RANKL, ectodomain shedding, osteoclastogenesis, MMP-14, ADAM10, soluble RANKL, osteoblasts
- MeSH terms
- ADAM10 Protein, Animals, Binding Sites, Bone Diseases, Metabolic, Bone Marrow, Humans, Macrophages, Membrane Proteins, Mice, Inbred C57BL, Osteoblasts, Osteoclasts, Down-Regulation, Coculture Techniques, Mice, ADAM Proteins, RANK Ligand, Matrix Metalloproteinase 14, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
